Heiser, V., Scherzinger, E., Boeddrich, A., Nordhoff, E., Lurz, R., Schugardt, N., . . . Wanker, E. E. (2000). Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy. National Academy of Sciences.
Citação norma ChicagoHeiser, Volker, Eberhard Scherzinger, Annett Boeddrich, Eckhard Nordhoff, Rudi Lurz, Nancy Schugardt, Hans Lehrach, and Erich E. Wanker. Inhibition of Huntingtin Fibrillogenesis By Specific Antibodies and Small Molecules: Implications for Huntington's Disease Therapy. National Academy of Sciences, 2000.
Citação norma MLAHeiser, Volker, et al. Inhibition of Huntingtin Fibrillogenesis By Specific Antibodies and Small Molecules: Implications for Huntington's Disease Therapy. National Academy of Sciences, 2000.